Literature DB >> 8695839

Recombinant human macrophage colony-stimulating factor in nonhuman primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells.

D H Munn1, A G Bree, A C Beall, M D Kaviani, H Sabio, R G Schaub, R K Alpaugh, L M Weiner, S J Goldman.   

Abstract

The CD16 receptor (Fc gamma R-III) is found on many tissue macrophages (M phi s), but its expression on circulating monocytes is restricted to a small, phenotypically distinct subset. The number of these CD16+ monocytes may be markedly increased in response to sepsis, human immunodeficiency virus infection, or metastatic malignancy. We have recently shown that the CD16+ monocyte population is selectively expanded by administration of recombinant human macrophage colony-stimulating factor (rhM-CSF). In the current study, we used the highly rhM-CSF-responsive cynomolgus primate model to further characterize this novel monocyte population. Animals treated with rhM-CSF underwent a progressive and essentially complete conversion to the CD16+ monocyte phenotype, with up to a 50-fold increase in the number of CD16+ cells. This increase was paralleled by the emergence of a population of circulating cells that morphologically resembled large granular lymphocytes (LGLs). However, quantitatively, this population corresponded closely to the number of CD16+ monocytes, and fluorescence-activated cell sorting (FACS) confirmed that they were the same. In addition to their LGL-like morphology, many rhM-CSF-induced CD16+ monocytes showed a pattern of size, granularity, and quantitative cell surface marker expression that closely resembled the pretreatment LGL/natural killer (NK) cell population but that did not resemble the pretreatment monocyte population. However, rhM-CSF-induced CD16+ monocytes could be distinguished from LGL/ NK cells by fact that they all expressed cell surface receptors for rhM-CSF, and many of them showed reduced but detectable phagocytic and respiratory burst activity. Studies of human subjects treated with rhM-CSF also showed an analogous population of "LGL-appearing" CD16+ mononuclear cells. Thus, our studies reveal a previously unsuspected ability of cells in the monocyte lineage to adopt a phenotype similar to that of LGL/NK cells. The extent of this phenotypic convergence suggests that the two lineages retain access to elements of a similar developmental pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695839

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

Authors:  G Fingerle-Rowson; M Angstwurm; R Andreesen; H W Ziegler-Heitbrock
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

2.  Differentiation Kinetics of Blood Monocytes and Dendritic Cells in Macaques: Insights to Understanding Human Myeloid Cell Development.

Authors:  Chie Sugimoto; Atsuhiko Hasegawa; Yohei Saito; Yayoi Fukuyo; Kevin B Chiu; Yanhui Cai; Matthew W Breed; Kazuyasu Mori; Chad J Roy; Andrew A Lackner; Woong-Ki Kim; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Immunol       Date:  2015-07-15       Impact factor: 5.422

3.  CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.

Authors:  A-L Feng; J-K Zhu; J-T Sun; M-X Yang; M R Neckenig; X-W Wang; Q-Q Shao; B-F Song; Q-F Yang; B-H Kong; X Qu
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

4.  Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys.

Authors:  Domenico Mavilio; Janet Benjamin; Diana Kim; Gabriella Lombardo; Marybeth Daucher; Audrey Kinter; Elizabeth Nies-Kraske; Emanuela Marcenaro; Alessandro Moretta; Anthony S Fauci
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

5.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

6.  Suppression of Plasmodium cynomolgi in rhesus macaques by coinfection with Babesia microti.

Authors:  Leonie M van Duivenvoorde; Annemarie Voorberg-van der Wel; Nicole M van der Werff; Gerco Braskamp; Edmond J Remarque; Ivanela Kondova; Clemens H M Kocken; Alan W Thomas
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

7.  Expansion of CD14+CD16+ monocytes in critically ill cardiac surgery patients.

Authors:  G Fingerle-Rowson; J Auers; E Kreuzer; P Fraunberger; M Blumenstein; L H Ziegler-Heitbrock
Journal:  Inflammation       Date:  1998-08       Impact factor: 4.092

8.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

9.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Authors:  Petronela Ancuta; Kuang-Yu Liu; Vikas Misra; Vanessa Sue Wacleche; Annie Gosselin; Xiaobo Zhou; Dana Gabuzda
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

10.  Transforming growth factor-β, macrophage colony-stimulating factor and C-reactive protein levels correlate with CD14(high)CD16+ monocyte induction and activation in trauma patients.

Authors:  Sonlee D West; Daniel Goldberg; Anna Ziegler; Michael Krencicki; Terry W Du Clos; Carolyn Mold
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.